{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:42:54Z","timestamp":1787654574213,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.therap.2018.11.016","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T12:00:47Z","timestamp":1550145647000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Glucocorticoids dosing in obese subjects: A systematic review"],"prefix":"10.1016","volume":"74","author":[{"given":"J\u00e9r\u00e9mie","family":"Delaleu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Destere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorry","family":"Hachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Decl\u00e8ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-6248","authenticated-orcid":false,"given":"C\u00e9lia","family":"Lloret-Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2018.11.016_bib0225","series-title":"Obesity and overweight","author":"World Health Organization","year":"2018"},{"issue":"1","key":"10.1016\/j.therap.2018.11.016_bib0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/all.12525","article-title":"Asthma and obesity in children: current evidence and potential systems biology approaches","volume":"70","author":"Frey","year":"2015","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.therap.2018.11.016_bib0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000381913","article-title":"Epidemiology and comorbidity in children with psoriasis and atopic eczema","volume":"231","author":"Augustin","year":"2015","journal-title":"Dermatol Basel Switz"},{"issue":"10","key":"10.1016\/j.therap.2018.11.016_bib0240","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/acr.20526","article-title":"Impact of obesity on functioning among women with systemic lupus erythematosus","volume":"63","author":"Katz","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.therap.2018.11.016_bib0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/17425255.2018.1440287","article-title":"Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters","volume":"14","author":"Smit","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.therap.2018.11.016_bib0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010814-124354","article-title":"Drug disposition in obesity: toward evidence-based dosing","volume":"55","author":"Knibbe","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.therap.2018.11.016_bib0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.therap.2018.11.016_bib0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00003088-198611030-00002","article-title":"Drug disposition in obese humans. An update","volume":"11","author":"Abernethy","year":"1986","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.therap.2018.11.016_bib0265","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/cei.12955","article-title":"Considerations for dosing immunoglobulin in obese patients","volume":"188","author":"Hodkinson","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.therap.2018.11.016_bib0270","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1592\/phco.27.8.1081","article-title":"Antimicrobial dosing considerations in obese adult patients","volume":"27","author":"Pai","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"13","key":"10.1016\/j.therap.2018.11.016_bib0275","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","article-title":"Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline","volume":"30","author":"Griggs","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.therap.2018.11.016_bib0280","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2165\/11317150-000000000-00000","article-title":"Pharmacology of morphine in obese patients: clinical implications","volume":"48","author":"Lloret-Linares","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"30","key":"10.1016\/j.therap.2018.11.016_bib0285","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1200\/JCO.2007.11.2938","article-title":"Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese","volume":"25","author":"Sparreboom","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.therap.2018.11.016_bib0290","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1067\/mcp.2000.110772","article-title":"The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect","volume":"68","author":"Varis","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.therap.2018.11.016_bib0295","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/bdd.2510150208","article-title":"Bioavailability and reversible metabolism of prednisone and prednisolone in man","volume":"15","author":"Garg","year":"1994","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"10.1016\/j.therap.2018.11.016_bib0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hon.2900110206","article-title":"Pharmacokinetics of high dose methylprednisolone and use in hematological malignancies","volume":"11","author":"Patel","year":"1993","journal-title":"Hematol Oncol"},{"issue":"3","key":"10.1016\/j.therap.2018.11.016_bib0305","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00541537","article-title":"Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults","volume":"30","author":"Szefler","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.therap.2018.11.016_bib0310","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/106002809002400301","article-title":"Characterization of dexamethasone binding in normal and uremic human serum","volume":"24","author":"Cummings","year":"1990","journal-title":"DICP"},{"issue":"5","key":"10.1016\/j.therap.2018.11.016_bib0315","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/bdd.2510100504","article-title":"Pharmacokinetics and dose linearity testing of methylprednisolone phosphate","volume":"10","author":"M\u00f6llmann","year":"1989","journal-title":"Biopharm Drug Dispos"},{"issue":"9","key":"10.1016\/j.therap.2018.11.016_bib0320","first-page":"610","article-title":"Pharmacokinetic interaction between endogenous cortisol and exogenous corticosteroids","volume":"50","author":"Rohatagi","year":"1995","journal-title":"Pharmazie"},{"issue":"8","key":"10.1016\/j.therap.2018.11.016_bib0325","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2003-022025","article-title":"11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone","volume":"88","author":"Cooper","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.therap.2018.11.016_bib0330","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jchromb.2005.09.007","article-title":"Simultaneous determination of 6beta-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity","volume":"826","author":"Hu","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"10.1016\/j.therap.2018.11.016_bib0335","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10517-006-0257-2","article-title":"Some mutations of exon-7 in cytochrome P450 gene 3A4 and their effect on 6beta-hydroxylation of cortisol","volume":"141","author":"Shchepotina","year":"2006","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"10.1016\/j.therap.2018.11.016_bib0340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-3565(25)12795-X","article-title":"Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation","volume":"277","author":"Gentile","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.therap.2018.11.016_bib0345","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF01064420","article-title":"Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man","volume":"20","author":"Wald","year":"1992","journal-title":"J Pharmacokinet Biopharm"},{"issue":"6","key":"10.1016\/j.therap.2018.11.016_bib0350","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/clpt.1989.196","article-title":"Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects","volume":"46","author":"Kong","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.therap.2018.11.016_bib0355","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10238-017-0459-0","article-title":"Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus","volume":"18","author":"Perez-Guerrero","year":"2018","journal-title":"Clin Exp Med"},{"issue":"4","key":"10.1016\/j.therap.2018.11.016_bib0360","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00296-017-3653-1","article-title":"Polymorphisms in the multidrug resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment","volume":"37","author":"Cuppen","year":"2017","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.therap.2018.11.016_bib0365","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/08916934.2016.1191476","article-title":"Effects of the multidrug resistance-1 gene on drug resistance in primary immune thrombocytopenia","volume":"49","author":"Liu","year":"2016","journal-title":"Autoimmunity"},{"issue":"1\u20132","key":"10.1016\/j.therap.2018.11.016_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.10.042","article-title":"Nonlinear absorption of methylprednisolone by absorptive and secretory transporters","volume":"387","author":"Tomita","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.therap.2018.11.016_bib0375","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.immunol.18.1.309","article-title":"Glucocorticoids in T cell development and function*","volume":"18","author":"Ashwell","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.therap.2018.11.016_bib0380","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1016\/j.therap.2018.11.016_bib0385","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1073\/pnas.97.8.3919","article-title":"Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell","volume":"97","author":"De Bosscher","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9935","key":"10.1016\/j.therap.2018.11.016_bib0390","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.therap.2018.11.016_bib0395","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.therap.2018.11.016_bib0400","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/clpt.1984.263","article-title":"Prednisolone disposition in obese men","volume":"36","author":"Milsap","year":"1984","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.therap.2018.11.016_bib0405","first-page":"311","article-title":"Pharmacokinetics of dexamethasone administered orally in obese patients","volume":"45","author":"Lamiable","year":"1990","journal-title":"Therapie"},{"issue":"5","key":"10.1016\/j.therap.2018.11.016_bib0410","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/clpt.1991.64","article-title":"Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity","volume":"49","author":"Dunn","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.therap.2018.11.016_bib0415","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-7075-2-3","article-title":"The role of glucocorticoid action in the pathophysiology of the metabolic syndrome","volume":"2","author":"Wang","year":"2005","journal-title":"Nutr Metab (Lond)"},{"issue":"1\u20132","key":"10.1016\/j.therap.2018.11.016_bib0420","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2008.01.012","article-title":"Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene","volume":"285","author":"Iwasaki","year":"2008","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.therap.2018.11.016_bib0425","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"10.1016\/j.therap.2018.11.016_bib0430","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jclinane.2004.01.009","article-title":"Anesthesia in the obese patient: pharmacokinetic considerations","volume":"17","author":"Casati","year":"2005","journal-title":"J Clin Anesth"},{"issue":"10","key":"10.1016\/j.therap.2018.11.016_bib0435","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40262-014-0166-x","article-title":"Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers","volume":"53","author":"Brill","year":"2014","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.therap.2018.11.016_bib0440","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/SLA.0b013e31827a0e82","article-title":"Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients","volume":"258","author":"Tandra","year":"2013","journal-title":"Ann Surg"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719300319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719300319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:52:56Z","timestamp":1758567176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595719300319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0040595719300319"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2018.11.016","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoids dosing in obese subjects: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2018.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}